Doximity Inc (DOCS) reports impressive Q4 results, exceeding revenue guidance and showcasing robust growth, while navigating macroeconomic challenges with strategic AI advancements.

Doximity reported fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of 38 cents, which beat the Zacks Consensus Estimate of 27 cents by 40.7%. The company also reported earnings of 25 cents ...

Doximity has been treading water for the past six months, holding steady at $58. However, the stock is beating the S&P 500’s ...

Q4 2025 Earnings Call Transcript May 15, 2025 Doximity, Inc. beats earnings expectations. Reported EPS is $0.38, expectations ...

Doximity DOCS reported fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of 38 cents, which beat the Zacks ...

Doximity (DOCS) stock drops 14% despite Q4 beat, as the company cites macro uncertainty in setting its fiscal 2026 and Q1 outlook below consensus. Read more here.

Phoenix-based Banner Health reported an operating income of $142.4 million (3.6% margin) in the first quarter, up from an $89.3 million operating gain (2.4% margin) in the first quarter of 2024, ...

Here's our initial take on Doximity's (NYSE: DOCS) financial report. Key Metrics Solid earnings but weak guidance At first glance, Doximity's earnings report looked rather strong. In its fiscal fourth ...

Cleveland Clinic reported an operating income of $52.8 million (1.3% margin) in the first quarter, up slightly from $50.2 million (1.3% margin) in the same period last year, according to financial ...

RBC Capital Markets cut its price target on Dr Martens on Monday to 60p form 70p and reduced its revenue and earnings per ...

Jon Rahm may have lost the PGA Championship Sunday, but it didn't look like a defeat. It looked like the start of something ...